ArticleFrontiers in pharmacology2024

Empagliflozin alters lipid metabolism in the myocardium and liver in a prediabetes model with severe dyslipidemia.

Denisa Miklankova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.